A research agenda for helminth diseases of humans: Intervention for control and elimination

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  Prichard, Roger K ^a   Basáñez, María Gloria ^b   Boatin, Boakye A ^a,c   McCarthy, James S ^d   García, Héctor H ^e   Yang, Guo Jing ^f   Sripa, Banchob ^g   Lustigman, Sara ^h  

^a MCGILL UNIVERSITY   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c University of Ghana   (Ghana)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^g KHON KAEN UNIVERSITY   (Thailand)

^h NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ARTEMISININ; BENZIMIDAZOLE; DERQUANTEL; DIETHYLCARBAMAZINE; DOXYCYCLINE; EMODEPSIDE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MONEPANTEL; MOXIDECTIN; NICLOSAMIDE; NITAZOXANIDE; OXFENDAZOLE; PRAZIQUANTEL; PYRANTEL; TRIBENDIMIDINE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

CLONORCHIASIS; COMMUNITY; CYSTICERCOSIS; DRUG MONITORING; ENDEMIC DISEASE; FASCIOLIASIS; FILARIASIS; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; LYMPHATIC FILARIASIS; MORBIDITY; ONCHOCERCIASIS; OPISTHORCHIASIS; PARASITE CONTROL; PARASITE TRANSMISSION; PARASITISM; REVIEW; SCHISTOSOMIASIS; SOIL; TAENIASIS; VECTOR CONTROL; ANIMAL; DRUG DEVELOPMENT; DRUG EFFECT; DRUG RESISTANCE; DRUG THERAPY; HELMINTH; INFECTION CONTROL; MEDICAL EDUCATION; METHODOLOGY;

ANIMALS; ANTHELMINTICS; COMMUNICABLE DISEASE CONTROL; DRUG DISCOVERY; DRUG RESISTANCE; DRUG THERAPY; EDUCATION, MEDICAL; HELMINTHIASIS; HELMINTHS; HUMANS;

EID: 84859005658     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001549     Document Type: Review

References (139)

1. Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin B, et al. (2012) A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis 6: e1582 doi:10.1371/journal.pntd.0001582.
2. Olliaro P, Seiler J, Kuesel A, Horton J, Clark JN, et al. (2011) Potential drug development candidates for human soil-transmitted helminthiases. PLoS Negl Trop Dis 5: e1138 doi:10.1371/journal.pntd.0001138.
3. Vercruysse J, Albonico M, Behnke J, Kotze A, Prichard R, et al. (2011) Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol: Drugs Drug Res 1: 14-27.
4. Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, et al. (2000) A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health 5: 842-847.
5. Ramaiah KD, Thiruvengadam B, Vanamail P, Subramanian S, Gunasekaran S, et al. (2009) Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health 14: 870-876.
6. Ramaiah KD, (2009) Lymphatic filariasis elimination programme in India: progress and challenges. Trends Parasitol 25: 7-8.
7. Lightowlers MW, (2010) Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int J Parasitol 40: 1183-1192.
8. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, et al. (2010) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40: 515-519.
9. Hougard JM, Alley ES, Yameogo L, Dadzie KY, Boatin BA, (2001) Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis 184: 497-503.
10. Utzinger J, Zhou XN, Chen MG, Bergquist R, (2005) Conquering schistosomiasis in China: the long march. Acta Trop 96: 69-96.
11. Curtis CF, Malecela-Lazaro M, Reuben R, Maxwell CA, (2002) Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus. Ann Trop Med Parasitol 96 (Suppl 2): S97-104.
12. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Dash AP, et al. (2007) Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. Bull World Health Organ 85: 138-145.
13. Guyatt HL, Brooker S, Kihamia CM, Hall A, Bundy DA, (2001) Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull World Health Organ 79: 695-703.
14. Brooker S, Kabatereine NB, Fleming F, Devlin N, (2008) Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up. Health Policy Plan 23: 24-35.
15. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, et al. (2007) Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 85: 91-99.
16. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, et al. (2006) Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
17. Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, et al. (2007) Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 77: 334-341.
18. Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, et al. (2007) Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med 5: 9.
19. Rodríguez-Pérez MA, Lizarazo-Ortega C, Hassan HK, Domínguez-Vásquez A, Mendez-Galván J, et al. (2008) Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico. Am J Trop Med Hyg 78: 147-152.
20. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, et al. (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497 doi:10.1371/journal.pntd.0000497.
21. French MD, Churcher TS, Gambhir M, Fenwick A, Webster JP, et al. (2010) Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl Trop Dis 4: e897 doi:10.1371/journal.pntd.0000897.
22. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
23. Molyneux DH, Hotez PJ, Fenwick A, (2005) "Rapid-Impact Interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2: e336 doi:10.1371/journal.pmed.0020336.
24. Kolaczinski JH, Kabatereine NB, Onapa AW, Ndyomugyenyi R, Kakembo AS, et al. (2007) Neglected tropical diseases in Uganda: the prospect and challenge of integrated control. Trends Parasitol 23: 485-493.
25. Utzinger J, Raso G, Brooker S, De Savigny D, Tanner M, et al. (2009) Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 136: 1859-1874.
26. Gazzinelli A, Correa-Oliveira R, Yang GJ, Boatin B, Kloos H, (2012) A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems. PLoS Negl Trop Dis 6: e1603 doi:10.1371/journal.pntd.0001603.
27. Basáñez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, et al. (2008) Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 8: 310-322.
28. Michael E, Malecela-Lazaro MN, Simonsen PE, Pedersen EM, Barker G, et al. (2004) Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis 4: 223-234.
29. Tisch DJ, Michael E, Kazura JW, (2005) Mass chemotherapy options to control lymphatic filariasis: a systematic review. Lancet Infect Dis 5: 514-523.
30. Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA, Habbema JD, (1997) Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull World Health Organ 75: 237-245.
31. Ndyomugyenyi R, Tukesiga E, Büttner DW, Garms R, (2004) The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda. Trop Med Int Health 9: 882-886.
32. Maxwell CA, Curtis CF, Haji H, Kisumku S, Thalib AI, et al. (1990) Control of Bancroftian filariasis by integrating therapy with vector control using polystyrene beads in wet pit latrines. Trans R Soc Trop Med Hyg 84: 709-714.
33. Curtis CF, Malecela-Lazaro M, Reuben R, Maxwell CA, (2002) Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus. Ann Trop Med Parasitol 96 (Suppl 2): S97-S104.
34. Penzer R, (2007) Lymphatic filariasis and the role of nursing interventions. J Lymphoedema 2: 48-53.
35. Karmakar PR, Mitra K, Chatterjee A, Jana PK, Bhattacharya S, et al. (2011) A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India. J Vector Borne Dis 48: 101-104.
36. Parker M, Allen T, (2011) Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda. Health Res Policy Syst 9: 3.
37. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP, (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2 (Suppl 1): S4.
38. Mackenzie C, Geary T, Prichard R, Boussinesq M, (2007) Where next with Loa loa encephalopathy?- Data are badly needed! Trends Parasitol 23: 237-238.
39. Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, et al. (2010) Analysis of single nucleotide polymorphisms in the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg 83: 28-32.
40. Addiss DG, Rheingans R, Nana AY, Twum-Danso NAY, Richards FO, (2003) A framework for decision-making for mass distribution of Mectizan® in areas endemic for Loa loa. Filaria J 2 (Suppl 1): S9.
41. Keiser J, Ingram K, Utzinger J, (2011) Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 24: 1620-1632.
42. Rodríguez-Pérez MA, Lizarazo-Ortega C, Hassan HK, Domínguez-Vásquez A, Mendez-Galván J, et al. (2008) Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico. Am J Trop Med Hyg 78: 147-152.
43. Rodríguez-Pérez MA, Lutzow-Steiner MA, Segura-Cabrera A, Lizarazo-Ortega C, Domínguez-Vázquez A, et al. (2008) Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan. Am J Trop Med Hyg 79: 239-244.
44. Keiser J, Utzinger J, (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 299: 1937-1948.
45. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, et al. (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40: 1-13.
46. Diawara A, Drake LJ, Suswillo RR, Kihara J, Bundy DAP, et al. (2009) Assays to detect β-tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides. PLoS Negl Trop Dis 3: e397 doi:10.1371/journal.pntd.0000397.
47. Diawara A, (2008) Development of DNA assays for the detection of single nucleotide polymorphism associated with benzimidazole resistance, in human soil-transmitted helminths [M.Sc. thesis]. McGill University.
48. Garba A, Touré S, Dembele R, Boisier P, Tohon Z, et al. (2009) Present and future schistosomiasis control activities with support from the Schistosomiasis Control Initiative in West Africa. Parasitology 136: 1731-1737.
49. Touré S, Zhang Y, Bosqué-Oliva E, Ky C, Ouedraogo A, et al. (2008) Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ 86: 780-787.
50. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, et al. (2007) Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 5: 27.
51. Clements AC, Firth S, Dembele R, Garba A, Touré S, et al. (2009) Use of Bayesian geostatistical prediction to estimate local variations in Schistosoma haematobium infection in western Africa. Bull World Health Organ 87: 921-929.
52. Clements AC, Deville MA, Ndayishimiye O, Brooker S, Fenwick A, (2010) Spatial co-distribution of neglected tropical diseases in the east African great lakes region: revisiting the justification for integrated control. Trop Med Int Health 15: 198-207.
53. Brooker S, Kabatereine NB, Myatt M, Russell Stothard J, et al. (2005) Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda. Trop Med Int Health 10: 647-658.
54. Garba A, Barkiré N, Djibo A, Lamine MS, Sofo B, et al. (2010) Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop 115: 212-219.
55. Utzinger J, Xiao SH, Tanner M, Keiser J, (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 8: 105-116.
56. Huyse T, Webster BL, Geldof S, Stothard JR, Diaw OT, et al. (2009) Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog 5: e1000571 doi:10.1371/journal.ppat.1000571.
57. Rudge JW, Lu DB, Fang GR, Wang TP, Basáñez MG, et al. (2009) Parasite genetic differentiation by habitat type and host species: molecular epidemiology of Schistosoma japonicum in hilly and marshland areas of Anhui Province, China. Mol Ecol 18: 2134-2147.
58. Lu DB, Wang TP, Rudge JW, Donnelly CA, Fang GR, et al. (2010) Contrasting reservoirs for Schistosoma japonicum between marshland and hilly regions in Anhui, China-a two-year longitudinal parasitological survey. Parasitology 137: 99-110.
59. Rudge JW, Carabin H, Balolong E, Tallo V, Shrivastava J, et al. (2008) Population genetics of Schistosoma japonicum within the Philippines suggest high levels of transmission between humans and dogs. PLoS Negl Trop Dis 2: e340 doi:10.1371/journal.pntd.0000340.
60. Riley S, Carabin H, Belisle P, Joseph L, Tallo V, et al. (2008) Multi-host transmission dynamics of Schistosoma japonicum in Samar province, the Philippines. PLoS Med 5: e18 doi:10.1371/journal.pmed.0050018.
61. Gray DJ, Williams GM, Li YS, Chen HG, Forsyth SJ, et al. (2009) A cluster-randomised intervention trial against S. japonicum in the Peoples' Republic of China: bovine and human transmission. PLoS ONE 4: e5900 doi:10.1371/journal.pone.0005900.
62. Wu HW, Qin YF, Chu K, Meng R, Liu Y, et al. (2010) High Prevalence of Schistosoma japonicum infection in water buffaloes in the Philippines assessed by real-time polymerase chain reaction. Am J Trop Med Hyg 82: 646-652.
63. Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, et al. (2008) DNA-based vaccine protects against zoonotic schistosomiasis in water buffalo. Vaccine 26: 3617-3625.
64. Report of the WHO Expert Consultation on Foodborne Trematode Infections and Taeniasis/Cysticercosis: http://www.who.int/neglected_diseases/preventive_chemotherapy/WHO_HTM_NTD_PCT_2011.3.pdf Accessed 20 December 2011.
65. Keiser J, Utzinger J, (2010) The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 73: 197-232.
66. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, et al. (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4: e201 doi:10.1371/journal.pmed.0040201.
67. Sripa B, Mairiang E, Thinkhamrop B, Laha T, Kaewkes S, et al. (2009) Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of IL-6. Hepatology 50: 1273-1281.
68. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, et al. (2010) Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120 (Suppl 1): S158-S168.
69. Bethony JM, Cole RN, Guo X, Kamhawi S, Lightowlers MW, et al. (2011) Vaccines to combat the neglected tropical diseases. Immunol Rev 239: 237-270 doi:10.1111/j.1600-065X.2010.00976.x.
70. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, et al. (2010) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40: 515-519.
71. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, et al. (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350: 249-258.
72. Garcia HH, Gonzalez AE, Del Brutto OH, Tsang VC, Llanos-Zavalaga F, et al. (2007) Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci 262: 153-157.
73. Steinmann P, Utzinger J, Du Z-W, Zhou X-N, (2010) Multiparasitism: a neglected reality on global, regional and local scale. Adv Parasitol 73: 21-50.
74. Eng JKL, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, et al. (2006) Ivermectin selection on β-tubulin: Evidence in Onchocerca volvulus and Haemonchus contortus. Mol Biochem Parasitol 150: 229-235.
75. Bourguinat C, Pion SDS, Kamgno J, Gardon J, Duke BOL, et al. (2007) Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis 1: e72 doi:10.1371/journal.pntd.0000072.
76. Mottier ML, Prichard RK, (2008) Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus. Pharmacogenet Genomics 18: 129-140.
77. Gray DJ, McManus DP, Li YS, Williams GM, Bergquist R, et al. (2010) Schistosomiasis elimination: lessons from the past guide the future. Lancet Inf Dis 10: 733-736.
78. Basáñez MG, McCarthy JS, French MD, Yang GJ, Walker M, et al. (2012) A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis 6: e1548 doi:10.1371/journal.pntd.0001548.
79. Liu YH, Qian MX, Wang XG, Quan YZ, Yan SH, et al. (1993) Levo-praziquantel versus praziquantel in experimental and clinical treatment of schistosomiasis japonica. Chin Med J (Engl) 106: 593-596.
80. Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, et al. (2011) Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol 72: 77-84.
81. Lima RM, Ferreira MA, de Jesus Ponte Carvalho TM, Dumêt Fernandes BJ, Takayanagui OM, et al. (2011) Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. Br J Clin Pharmacol 71: 528-535.
82. Keiser J, Vargas M, (2010) Effect of artemether, artesunate, OZ78, praziquantel, and tribendimidine alone or in combination chemotherapy on the tegument of Clonorchis sinensis. Parasitol Int 59: 472-476.
83. Duthaler U, Smith TA, Keiser J, (2010) In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78. Antimicrob Agents Chemother 54: 4596-4604.
84. Hu Y, Platzer EG, Bellier A, Aroian RV, (2010) Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proc Natl Acad Sci U S A 107: 5955-5960.
85. Dobson RJ, Besier RB, Barnes EH, Love SC, Vizard A, et al. (2001) Principles for the use of macrocyclic lactones to minimise selection for resistance. Aust Vet J 79: 756-761.
86. Leathwick DM, Hosking BC, Bisset SA, McKay CH, (2009) Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class? N Z Vet J 57: 181-192.
87. Coles GC, Roush RT, (2001) Slowing the spread of anthelmintic resistant nematodes of sheep and goats in the United Kingdom. Vet Rec 130: 505-510.
88. van Wyk JA, (2001) Refugia-overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance. Onderstepoort J Vet Res 68: 55-67.
89. Curtis CF, (1985) Theoretical models of the use of insecticide mixtures for the management of resistance. Bull Entomol Res 75: 259-265.
90. Lespine A, Menez C, Bourguinat C, Prichard R, (2012) P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance. Int J Parasitol Drugs Drug Res 2: 58-75.
91. Kerboeuf D, Blackhall W, Kaminsky R, von Samson-Himmelstjerna G, (2003) P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int J Antimicrob Agents 22: 332-346.
92. Blackhall WJ, Prichard RK, Beech RN, (2008) P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet Parasitol 152: 101-107.
93. von Samson-Himmelstjerna G, Prichard RK, Wolstenholme AJ, (2009) Anthelmintic resistance as a guide to the discovery of new drugs. In: Selzer P, editors. Drug Discovery in Infectious Diseases Weinheim Wiley-VCH pp. 17-32.
94. Hu Y, Xiao SH, Aroian RV, (2009) The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist. PLoS Negl Trop Dis 3: e499 doi:10.1371/journal.pntd.0000499.
95. Hong ST, Fang Y, (2012) Clonorchis sinensis and clonorchiasis, an update. Parasitol Int 61: 17-24.
96. Tritten L, Silbereisen A, Keiser J, (2012) In vitro and in vivo efficacy of monepantel (AAD 1566) against laboratory models of human intestinal nematode infections. PLoS Negl Trop Dis In press.
97. Murdoch ME, (2010) Onchodermatitis. Curr Opin Infect Dis 23: 124-131.
98. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, et al. (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 5: e998 doi:10.1371/journal.pntd.0000998.
99. Cobb R, Boeckh A, (2009) Moxidectin: a review of chemistry, pharmacokinetics and use in horses. Parasit Vectors 2 (Suppl 2): S5.
100. DNDi R&D Projects- 2011 Outlook Flubendazole Macrofilaricide (Helminth): http://www.dndi.org/portfolio/flubendazole-macrofilaricide.html Accessed 20 December 2011.
101. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, et al. (2009) Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2: 39.
102. Slatko BE, Taylor MJ, Foster JM, (2010) The Wolbachia endosymbiont as an anti-filarial nematode target. Symbiosis 51: 55-65.
103. Lustigman S, Geldhof P, Grant WN, Osei-Atweneboana MY, Sripa B, et al. (2012) A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. PLoS Negl Trop Dis 6: e1445 doi:10.1371/journal.pntd.0001445.
104. Garcia HH, González AE, Del Brutto OH, Tsang VC, Llanos-Zavalaga F, et al. (2007) Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci 262: 153-157.
105. Fürst T, Keiser J, Utzinger J, (2012) Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12: 210-221.
106. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, et al. (2010) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40: 515-519.
107. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, et al. (2011) Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis 204: 1437-1449.
108. Kasný M, Mikes L, Hampl V, Dvorák J, Caffrey CR, et al. (2009) Peptidases of trematodes. Adv Parasitol 69: 205-297.
109. Knox D, (2011) Proteases in blood-feeding nematodes and their potential as vaccine candidates. In: Robinson MW, Dalton JP, editors. Cysteine proteases of pathogenic organisms. Adv Exp Med Biol 712: 155-176.
110. Zhang W, Li J, Duke M, Jones MK, Kuang L, et al. (2011) Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target. PLoS Negl Trop Dis 5: e1166 doi:10.1371/journal.pntd.0001166.
111. Hotez PJ, Ferris MT, (2006) The antipoverty vaccines. Vaccine 24: 5787-5799.
112. Hotez PJ, Brown AS, (2009) Neglected tropical disease vaccines. Biologicals 37: 160-164.
113. Ghosh K, Wu W, Antoine AD, Bottazzi ME, Valenzuela JG, et al. (2006) The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters. J Infect Dis 193: 155-162.
114. Bergquist R, Lustigman S, (2010) Control of important helminthic infections: vaccine development as part of the solution. Adv Parasitol 73: 297-326.
115. Hotez PJ, Bethony JM, Oliveira SC, Brindley PJ, Loukas A, (2008) Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines 7: 745-752.
116. Lustigman S, Abraham D, (2008) Onchocerciasis. In: Barrett ADT, Stanberry LR, editors. Vaccines for Biodefense and Emerging and Neglected Diseases: Academic Press Inc- Elsevier Science & Technology Chapter 67: 1379-1400.
117. McCarthy JS, Lustigman S, Yang GJ, Barakat RM, García HH, et al. (2012) A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis 6: e1601 doi:10.1371/journal.pntd.0001601.
118. Smits HL, (2009) Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev Anti Infect Ther 7: 37-56.
119. Ottesen EA, Duke BOL, Karam M, Behbehani K, (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bull. World Health Organ 75: 491-503.
120. Chanteau S, Roux JF, (2008) Filariose lymphatique de Bancroft: vers l'élimination dans le Pacifique? Bull Soc Pathol Exot 101: 254-260.
121. Ottesen EA, Hooper PJ, Bradley M, Biswas G, (2008) The Global Programme to Eliminate Lymphatic Filariasis: health impact after 8 years. PLoS Negl Trop Dis 2: e317 doi:10.1371/journal.pntd.0000317.
122. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC, (2004) Drug resistance in veterinary helminths. Trends Parasitol 20: 469-476.
123. Martin PJ, Anderson N, Jarrett RG, (1989) Detecting benzimidazole resistance with faecal egg count reduction tests and in vitro assays. Aust Vet J 66: 236-240.
124. Eberhard ML, Lammie PJ, Dickinson CM, Roberts JM, (1991) Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. J Inf Dis 163: 1157-1160.
125. Eberhard ML, Lowrie RC Jr, Lammie PJ, (1988) Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy. Trop Med Parasitol 39: 128-130.
126. Dixit V, Gupta AK, Prasad GB, (2009) Interruption of annual single dose DEC regimen administration: impact on Wuchereria bancrofti microfilaraemia, vector infection and infectivity rates. J Commun Dis 41: 25-31.
127. Hampshire VA, (2005) Evaluation of efficacy of heartworm preventive products at the FDA. Vet Parasitol 133: 191-195.
128. Bourguinat C, Keller K, Blagburn B, Schenker R, Geary TG, et al. (2011) Correlation between loss of efficacy of macrocyclic lactone heartworm preventatives and P-glycoprotein genotype. Vet Parasitol 176: 374-381.
129. Bourguinat C, Keller K, Bhan A, Peregrine AS, Geary TG, et al. (2011) Macrocyclic lactone resistance in Dirofilaria immitis. Vet Parasitol 181: 388-392.
130. Blagburn BL, Dillon AR, Arthur RG, Butler JM, Newton JC, (2011) Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis. Vet Parasitol 176: 189-194.
131. Churcher TS, Pion SDS, Osei-Atweneboana MY, Prichard RK, Awadzi K, et al. (2009) Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci, USA 106: 16716-16726.
132. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, et al. (2009) Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136: 1825-1835.
133. Blanton RE, Blank WA, Costa JM, Carmo TM, Reis EA, et al. (2011) Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil. Int J Parasitol 41: 1093-1099.
134. Fairweather I, (2011) Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? Vet Parasitol 180: 133-143.
135. Alum A, Rubino JR, Ijaz MK, (2010) The global war against intestinal parasites-should we use a holistic approach? Int J Inf Dis 14: e732-e738.
136. Harhay MO, Horton J, Olliaro PL, Utzinger J, (2011) Diagnostics are central for a truly holistic approach against intestinal parasitic diseases. Int J Inf Dis 15: e76-e77.
137. Churcher TS, Kaplan RM, Ardelli BF, Schwenkenbecher JM, Basáñez MG, et al. (2010) Mass treatment of parasitic disease: implications for the development and spread of anthelmintic resistance. In: Todd Weber J, editors. Antimicrobial Resistance - Beyond the Breakpoint vol 6: 1-18 Issues Infect Dis. Basel, Karger.
138. Yuan H, Jiagang G, Bergquist R, Tanner M, Xianyi C, et al. (2000) The 1992-1999 World Bank schistosomiasis research initiative in China: outcome and perspectives. Parasitology Int 49: 195-207.
139. Stepek G, Buttle DJ, Duce IR, Behnke JM, (2006) Human gastrointestinal nematode infections: are new control methods required? Int J Exp Pathol 87: 325-341.